| Literature DB >> 24309112 |
Mitsuru Imamura1, Oh Sasaki1, Katsuhide Okunishi1, Kazuyuki Nakagome1, Hiroaki Harada1, Kimito Kawahata1, Ryoichi Tanaka1, Kazuhiko Yamamoto1, Makoto Dohi2.
Abstract
Perillyl alcohol (POH) is an isoprenoid which inhibits farnesyl transferase and geranylgeranyl transferase, key enzymes that induce conformational and functional changes in small G proteins to conduct signal production for cell proliferation. Thus, it has been tried for the treatment of cancers. However, although it affects the proliferation of immunocytes, its influence on immune responses has been examined in only a few studies. Notably, its effect on antigen-induced immune responses has not been studied. In this study, we examined whether POH suppresses Ag-induced immune responses with a mouse model of allergic airway inflammation. POH treatment of sensitized mice suppressed proliferation and cytokine production in Ag-stimulated spleen cells or CD4(+) T cells. Further, sensitized mice received aerosolized OVA to induce allergic airway inflammation, and some mice received POH treatment. POH significantly suppressed indicators of allergic airway inflammation such as airway eosinophilia. Cytokine production in thoracic lymph nodes was also significantly suppressed. These results demonstrate that POH suppresses antigen-induced immune responses in the lung. Considering that it exists naturally, POH could be a novel preventive or therapeutic option for immunologic lung disorders such as asthma with minimal side effects.Entities:
Keywords: Airway inflammation; Asthma; Isoprenoid; POH; Perillyl alcohol (POH); perillyl alcohol
Mesh:
Substances:
Year: 2013 PMID: 24309112 DOI: 10.1016/j.bbrc.2013.11.106
Source DB: PubMed Journal: Biochem Biophys Res Commun ISSN: 0006-291X Impact factor: 3.575